PROCEPT BioRobotics ( NASDAQ: PRCT ) on Monday announced the commencement of an underwritten public offering of $175M shares of its common stock. A selling stockholder also expects to grant the underwriters a 30-day option to purchase up to an additional $26.25M shares of the.
